Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001345099-25-000010
Filing Date
2025-02-25
Accepted
2025-02-25 16:06:51
Documents
8
Period of Report
2025-02-24

Document Format Files

Seq Description Document Type Size
1 6-K a2025-02x25directorappoint.htm 6-K 22584
2 EX-99.1 exhibit991.htm EX-99.1 9154
3 EX-99.2 exhibit992.htm EX-99.2 4118
4 exhibit991001.jpg GRAPHIC 271009
5 exhibit991002.jpg GRAPHIC 272695
6 exhibit992001.jpg GRAPHIC 104823
7 exhibit992002.jpg GRAPHIC 106314
8 exhibit992003.jpg GRAPHIC 36852
  Complete submission text file 0001345099-25-000010.txt   1127615
Mailing Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000
Business Address LEVEL 38 55 COLLINS STREET MELBOURNE, VICTORIA C3 3000 613 9639 6036
MESOBLAST LTD (Filer) CIK: 0001345099 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 001-37626 | Film No.: 25663052
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)